Literature DB >> 18599502

Lung EC-SOD overexpression attenuates hypoxic induction of Egr-1 and chronic hypoxic pulmonary vascular remodeling.

Eva Nozik-Grayck1, Hagir B Suliman, Susan Majka, Joseph Albietz, Zachary Van Rheen, Kevin Roush, Kurt R Stenmark.   

Abstract

Although production of reactive oxygen species (ROS) such as superoxide (O(2)(.-)) has been implicated in chronic hypoxia-induced pulmonary hypertension (PH) and pulmonary vascular remodeling, the transcription factors and gene targets through which ROS exert their effects have not been completely identified. We used mice overexpressing the extracellular antioxidant enzyme extracellular superoxide dismutase (EC-SOD TG) to test the hypothesis that O(2)(.-) generated in the extracellular compartment under hypoxic conditions contributes to PH through the induction of the transcription factor, early growth response-1 (Egr-1), and its downstream gene target, tissue factor (TF). We found that chronic hypoxia decreased lung EC-SOD activity and protein expression in wild-type mice, but that EC-SOD activity remained five to seven times higher in EC-SOD TG mice under hypoxic conditions. EC-SOD overexpression attenuated chronic hypoxic PH, and vascular remodeling, measured by right ventricular systolic pressures, proliferation of cells in the vessel wall, muscularization of small pulmonary vessels, and collagen deposition. EC-SOD overexpression also prevented the early hypoxia-dependent upregulation of the redox-sensitive transcription factor Egr-1 and the procoagulant protein TF. These data provide the first evidence that EC-SOD activity is disrupted in chronic hypoxia, and increased EC-SOD activity can attenuate chronic hypoxic PH by limiting the hypoxic upregulation of redox-sensitive genes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18599502      PMCID: PMC2536799          DOI: 10.1152/ajplung.90293.2008

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  53 in total

1.  Generation of oxidative stress contributes to the development of pulmonary hypertension induced by hypoxia.

Authors:  Y Hoshikawa; S Ono; S Suzuki; T Tanita; M Chida; C Song; M Noda; T Tabata; N F Voelkel; S Fujimura
Journal:  J Appl Physiol (1985)       Date:  2001-04

2.  Extracellular superoxide dismutase in vessels and airways of humans and baboons.

Authors:  T D Oury; B J Day; J D Crapo
Journal:  Free Radic Biol Med       Date:  1996       Impact factor: 7.376

3.  Hypoxia-associated induction of early growth response-1 gene expression.

Authors:  S F Yan; J Lu; Y S Zou; J Soh-Won; D M Cohen; P M Buttrick; D R Cooper; S F Steinberg; N Mackman; D J Pinsky; D M Stern
Journal:  J Biol Chem       Date:  1999-05-21       Impact factor: 5.157

4.  Egr-1 induces the expression of its corepressor nab2 by activation of the nab2 promoter thereby establishing a negative feedback loop.

Authors:  Joerg Kumbrink; Marco Gerlinger; Judith P Johnson
Journal:  J Biol Chem       Date:  2005-10-31       Impact factor: 5.157

5.  Altered expression of extracellular superoxide dismutase in mouse lung after bleomycin treatment.

Authors:  C L Fattman; C T Chu; S M Kulich; J J Enghild; T D Oury
Journal:  Free Radic Biol Med       Date:  2001-11-15       Impact factor: 7.376

6.  Transgenic extracellular superoxide dismutase protects postnatal alveolar epithelial proliferation and development during hyperoxia.

Authors:  Richard L Auten; Michael A O'Reilly; Tim D Oury; Eva Nozik-Grayck; Mary H Whorton
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2005-08-12       Impact factor: 5.464

7.  Bicarbonate-dependent superoxide release and pulmonary artery tone.

Authors:  Eva Nozik-Grayck; Yuh-Chin T Huang; Martha Sue Carraway; Claude A Piantadosi
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-07-03       Impact factor: 4.733

8.  Superoxide dismutase-3 promotes full expression of the EPO response to hypoxia.

Authors:  Hagir B Suliman; Mervat Ali; Claude A Piantadosi
Journal:  Blood       Date:  2004-03-11       Impact factor: 22.113

9.  Tissue factor transcription driven by Egr-1 is a critical mechanism of murine pulmonary fibrin deposition in hypoxia.

Authors:  S F Yan; Y S Zou; Y Gao; C Zhai; N Mackman; S L Lee; J Milbrandt; D Pinsky; W Kisiel; D Stern
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-07       Impact factor: 11.205

10.  Overexpression of extracellular superoxide dismutase reduces acute radiation induced lung toxicity.

Authors:  Zahid N Rabbani; Mitchell S Anscher; Rodney J Folz; Emerald Archer; Hong Huang; Liguang Chen; Maria L Golson; Thaddeus S Samulski; Mark W Dewhirst; Zeljko Vujaskovic
Journal:  BMC Cancer       Date:  2005-06-10       Impact factor: 4.430

View more
  67 in total

1.  Lung extracellular superoxide dismutase overexpression lessens bleomycin-induced pulmonary hypertension and vascular remodeling.

Authors:  Zachary Van Rheen; Cheryl Fattman; Shannon Domarski; Susan Majka; Dwight Klemm; Kurt R Stenmark; Eva Nozik-Grayck
Journal:  Am J Respir Cell Mol Biol       Date:  2010-06-10       Impact factor: 6.914

Review 2.  Reactive oxygen and nitrogen species in pulmonary hypertension.

Authors:  Diana M Tabima; Sheila Frizzell; Mark T Gladwin
Journal:  Free Radic Biol Med       Date:  2012-03-06       Impact factor: 7.376

3.  Histone acetylation regulates the cell-specific and interferon-γ-inducible expression of extracellular superoxide dismutase in human pulmonary arteries.

Authors:  Igor N Zelko; Marcus W Stepp; Alan L Vorst; Rodney J Folz
Journal:  Am J Respir Cell Mol Biol       Date:  2011-04-14       Impact factor: 6.914

4.  Intermittent hypoxia augments pulmonary vascular smooth muscle reactivity to NO: regulation by reactive oxygen species.

Authors:  Charles E Norton; Nikki L Jernigan; Nancy L Kanagy; Benjimen R Walker; Thomas C Resta
Journal:  J Appl Physiol (1985)       Date:  2011-07-14

5.  Pulmonary artery endothelial cell dysfunction and decreased populations of highly proliferative endothelial cells in experimental congenital diaphragmatic hernia.

Authors:  Shannon N Acker; Gregory J Seedorf; Steven H Abman; Eva Nozik-Grayck; David A Partrick; Jason Gien
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-10-11       Impact factor: 5.464

Review 6.  NADPH oxidase-derived ROS and the regulation of pulmonary vessel tone.

Authors:  G Frazziano; H C Champion; P J Pagano
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-03-16       Impact factor: 4.733

7.  Exacerbated pulmonary arterial hypertension and right ventricular hypertrophy in animals with loss of function of extracellular superoxide dismutase.

Authors:  Dachun Xu; Haipeng Guo; Xin Xu; Zhongbing Lu; John Fassett; Xinli Hu; Yawei Xu; Qizhu Tang; Dayi Hu; Arif Somani; Aron M Geurts; Eric Ostertag; Robert J Bache; E Kenneth Weir; Yingjie Chen
Journal:  Hypertension       Date:  2011-07-05       Impact factor: 10.190

8.  Superoxide dismutase mimetic, MnTE-2-PyP, attenuates chronic hypoxia-induced pulmonary hypertension, pulmonary vascular remodeling, and activation of the NALP3 inflammasome.

Authors:  Leah R Villegas; Dylan Kluck; Carlie Field; Rebecca E Oberley-Deegan; Crystal Woods; Michael E Yeager; Karim C El Kasmi; Rashmin C Savani; Russell P Bowler; Eva Nozik-Grayck
Journal:  Antioxid Redox Signal       Date:  2013-02-05       Impact factor: 8.401

9.  Chronic hypoxia limits H2O2-induced inhibition of ASIC1-dependent store-operated calcium entry in pulmonary arterial smooth muscle.

Authors:  Danielle R Plomaritas; Lindsay M Herbert; Tracylyn R Yellowhair; Thomas C Resta; Laura V Gonzalez Bosc; Benjimen R Walker; Nikki L Jernigan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-07-03       Impact factor: 5.464

10.  NFAT is required for spontaneous pulmonary hypertension in superoxide dismutase 1 knockout mice.

Authors:  Juan Manuel Ramiro-Diaz; Carlos H Nitta; Levi D Maston; Simon Codianni; Wieslawa Giermakowska; Thomas C Resta; Laura V Gonzalez Bosc
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-03-08       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.